Unlock better mental wellness with TMS therapy.
Our first event for NeuroTranscend hosted by BTL! The educational bus tour is coming to Corewell Royal Oak on Thursday August 7th from 12-2pm. Come meet Dr Veyna and learn about this cutting edge device! Free Demos!
DaysDays
HrsHours
MinsMinutes
SecsSeconds
At NeuroTranscend, we believe in unlocking the brain’s innate ability to heal, focus, and thrive—without the need for medication or invasive treatments. Powered by the groundbreaking ExoMind technology, we offer a non-invasive, FDA-cleared therapy that’s helping patients across the country transform their mental health
✔️ Medical oversight from a neurosurgeon
✔️ Customized treatment plans
✔️ Soothing, environment
✔️ Supportive care team that listens
✔️ Flexible scheduling and fast results
At NeuroTranscend, we offer more than just a
device—we deliver a transformational experience. Founded by a neurosurgeon and a team of regenerative health experts, our mission is to bring cutting-edge, non-pharmaceutical brain therapy to those who need it most.
Dr. Richard Veyna is a board‑certified neurosurgeon with nearly 25 years of experience treating complex spine and brain disorders, including traumatic brain injury, deep brain stimulation, and spinal pathology . He serves as the Founder and Medical Director of NeuroTranscend and is dedicated to advancing brain health through innovative, non-invasive care.
Dr. Veyna trained at the University of Texas Health Science Center (valedictorian) and completed his neurosurgery residency at Henry Ford Hospital in Detroit . His fellowships and academic roles include specialty training in peripheral nerve surgery and a professorship in neurosurgery at Oakland University William Beaumont School of Medicine .
Deeply committed to preventative wellness, Dr. Veyna champions cutting‑edge treatments like ExoMind to help patients regain cognitive clarity, emotional balance, and long‑term neurological resilience. He is also an advocate for under-served groups—working with veterans and first responders to raise awareness for conditions like chronic traumatic encephalopathy (CTE), hormonal imbalance, and neuro‑endocrine fallout after head injuries
Please reach us at info@NeuroTranscendTMS.com if you cannot find an answer to your question.
ExoMind is FDA-cleared for treatment-resistant depression. It is also being studied and used off-label to support:
Note: Off-label use means it’s not yet FDA-approved for those conditions, but early studies and clinical use show promising results.
Unlike traditional TMS therapy that often requires daily visits for over a month, ExoMind uses a more advanced, efficient protocol. Most patients only need: One 30-minute session per week for 6 weeks
ExoMind’s cutting-edge technology delivers a higher level of neuromodulation in each session, allowing the brain to respond more quickly and efficiently. Clinical studies and patient outcomes show that this once-weekly protocol can provide the same or better results compared to older daily-based systems.
After your 6-session protocol, we’ll reassess your progress. Some patients continue with:
Every brain is different—we’ll personalize your care to match your goals.
Neuro Transcend is open Monday through Friday from 8am to 5pm. We are closed on Sundays and major holidays.
Yes. ExoMind is non-invasive, drug-free, and has minimal side effects. The most common sensations are a light tapping feeling on the scalp and mild fatigue or headache in a small percentage of patients.
Not at all. You may feel a light pulsing or tapping sensation where the device is positioned, but it’s well-tolerated and completely non-painful.
No referral is needed. You can schedule a free consultation directly through our office or online booking system.
Some patients notice changes in mood or clarity within the first or second session, while others may see gradual improvements over the full 6-week protocol. Brain rewiring takes time—and we’re here to support you every step of the wayAdd an answer to this item.
While TMS therapy is often covered by insurance, approval can be difficult to obtain—especially for newer protocols like ExoMind. Many patients face frustrating delays, strict requirements, or high out-of-pocket costs even after approval.
At NeuroTranscend, we believe mental health care shouldn’t come with loopholes or long waiting periods. That’s why we’ve chosen to offer direct-access pricing with flexible payment options like Affirm and Klarna, so you can begin treatment right away.
In fact, our 6-week protocol is often less than most insurance deductibles—without the paperwork or red tape.
We’re happy to walk you through costs, financing options, and what to expect during your free consultation.
Yes! There’s no downtime with ExoMind. You can drive, work, and go about your day as normal immediately after treatment
Side effects are rare but may include:
These usually resolve within a few hours, and most patients report feeling calm, focused, and energized after treatment.
3555 West 13 Mile Road, Suite N220, Royal Oak, MI, USA
Open today | 09:00 am – 05:00 pm |
Note: While only depression is FDA-cleared, all other uses are either off-label or under study. We always review each patient’s history to ensure responsible, personalized care.Patient results and experience may vary. BTL devices should only be used under the continued supervision of a physician or licensed practitioner. Refer to the owner's manual for the full list of contraindications, side effects, and precautions. †EXOMIND is intended to be used for the treatment of Major Depressive Disorder (MDD) in adult patients who have failed to achieve satisfactory improvement from prior antidepressant medication in the current episode. BTL®, EMSCULPT NEO®, NEO™, EMSCULPT®, EMSELLA®, EXILIS®, EMTONE®, HIFEM®, HIFES®, EMFEMME 360®, Core to floor®, EXION®, EMFACE®, ExoTMS™ and EXOMIND™ are trademarks and/or registered trademarks in the United States of America, the European Union, and other countries. The products, the methods of manufacture or their use may be protected by one or more U.S. or foreign patents or pending applications, see www.btlnet.com/patents. Trademarks EMSCULPT, EMSCULPT NEO, EMSELLA, EMTONE, EMFEMME 360, EMFACE and EMBODY are associated with the EM® family of products and services.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.